Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Tatnic who wrote (3408)	12/4/2000 7:40:21 PM
From: DanZ	Read Replies (2) \| Respond to of 5582

CC, Stocks aren't always rationale in the short term. Greed and fear dictate where stocks trade in the short term, and it looked like fear gripped this stock today. At one point the spread was almost $1 as people dumped stock on the bid without regard for where the offer was. This is more indicative of a bottom than a top. I am bruised but not out, and I have no doubt that GUMM will trade significantly higher than today's close in the future. I will not put a time frame on this because nobody can predict stock prices with any degree of certainty or consistency. Technical analysis is a good tool for reducing risk, but it can not be used to predict whether people will buy or sell stocks in the future. IMO, the reason that GUMM has gotten to this low point is because the company is not promoting itself. Don't read promotion as hype. There is nothing wrong with telling investors, analysts, fund managers, etc what you are doing and where you are going. Since the company hasn't been promoting itself, the volume has been low. The shorts took advantage of this and successfully moved the stock down to a point where margin selling hit it. This is a risk of the stock market, but it shouldn't be confused with the fair value of a company. Anyone who takes an honest look at this company's target markets, products, customers, joint ventures, sales, and earnings potential should conclude that the stock is worth much more than $60 million or even $100 million.